Skip to main content
Marina Basina, MD, Endocrinology, Stanford, CA

MarinaBasinaMD

Endocrinology Stanford, CA

Diabetes, Lipid Metabolism, Thyroid

Clin Prof, Medicine - Endocrinology, Gerontology, & Metabolism, Stanford University Medical Center

Dr. Basina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Basina's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
  • UCLA-VA Greater Los Angeles
    UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1998 - 2001
  • Moscow State University of Medicine and Dentistry
    Moscow State University of Medicine and DentistryClass of 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2000 - 2026
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Fellows Teaching Award Stanford University Department of Medicine, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Fellows Teaching Award Stanford University School of Medicine, 2010

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Weekly Insulin Shots for Type 2 Diabetes May Be as Effective as Daily Shots
    Weekly Insulin Shots for Type 2 Diabetes May Be as Effective as Daily ShotsSeptember 11th, 2024
  • Statin Use Associated with Type 2 Diabetes Progression
    Statin Use Associated with Type 2 Diabetes ProgressionOctober 9th, 2021
  • Type 1 Diabetes and Heart Disease Risk: What You Should Know
    Type 1 Diabetes and Heart Disease Risk: What You Should KnowFebruary 24th, 2020
  • Join now to see all

Grant Support

  • Rosiglitazone-Induced Weight GAINNational Center For Research Resources2006–2008